{"id":3090,"date":"2023-11-08T14:39:06","date_gmt":"2023-11-08T13:39:06","guid":{"rendered":"https:\/\/www.unioviedo.es\/IUOPA\/?p=3090"},"modified":"2023-11-08T14:39:06","modified_gmt":"2023-11-08T13:39:06","slug":"plain-language-summary-of-the-himalaya-study-tremelimumab-and-durvalumab-for-unresectable-hepatocellular-carcinoma-liver-cancer","status":"publish","type":"post","link":"https:\/\/www.unioviedo.es\/IUOPA\/en\/plain-language-summary-of-the-himalaya-study-tremelimumab-and-durvalumab-for-unresectable-hepatocellular-carcinoma-liver-cancer\/","title":{"rendered":"Plain language summary of the HIMALAYA study: tremelimumab and durvalumab for unresectable hepatocellular carcinoma (liver cancer)."},"content":{"rendered":"<p><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"background-color: rgba(255,255,255,0);background-position: center center;background-repeat: no-repeat;border-width: 0px 0px 0px 0px;border-color:#eae9e9;border-style:solid;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-justify-content-center\" style=\"max-width:1216.8px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\"><style type=\"text\/css\">@media only screen and (max-width:1024px) {.fusion-title.fusion-title-1{margin-top:0px!important; margin-right:0px!important;margin-bottom:20px!important;margin-left:0px!important;}}@media only screen and (max-width:640px) {.fusion-title.fusion-title-1{margin-top:0px!important; margin-right:0px!important;margin-bottom:20px!important; margin-left:0px!important;}}<\/style><div class=\"fusion-title title fusion-title-1 fusion-sep-none fusion-title-text fusion-title-size-one\" style=\"font-size:30px;margin-top:0px;margin-right:0px;margin-bottom:20px;margin-left:0px;\"><h1 class=\"title-heading-left fusion-responsive-typography-calculated\" style=\"margin:0;font-size:1em;--fontSize:30;line-height:1.1;\">Plain language summary of the HIMALAYA study: tremelimumab and durvalumab for unresectable hepatocellular carcinoma (liver cancer).<\/h1><\/div><div ><span class=\" fusion-imageframe imageframe-none imageframe-1 hover-type-zoomin\"><a href=\"https:\/\/www.unioviedo.es\/IUOPA\/wp-content\/uploads\/2022\/03\/OfertaTrabajo.jpg\" class=\"fusion-lightbox\" data-rel=\"iLightbox[01a353ee0f40b6864cf]\" data-title=\"Publicaciones\" title=\"Publicaciones\"><img decoding=\"async\" width=\"1905\" height=\"607\" src=\"https:\/\/www.unioviedo.es\/IUOPA\/wp-content\/uploads\/2022\/03\/OfertaTrabajo.jpg\" data-orig-src=\"https:\/\/www.unioviedo.es\/IUOPA\/wp-content\/uploads\/2022\/03\/OfertaTrabajo.jpg\" alt class=\"lazyload img-responsive wp-image-1824\" srcset=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%271905%27%20height%3D%27607%27%20viewBox%3D%270%200%201905%20607%27%3E%3Crect%20width%3D%271905%27%20height%3D%27607%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\" data-srcset=\"https:\/\/www.unioviedo.es\/IUOPA\/wp-content\/uploads\/2022\/03\/OfertaTrabajo-200x64.jpg 200w, https:\/\/www.unioviedo.es\/IUOPA\/wp-content\/uploads\/2022\/03\/OfertaTrabajo-400x127.jpg 400w, https:\/\/www.unioviedo.es\/IUOPA\/wp-content\/uploads\/2022\/03\/OfertaTrabajo-600x191.jpg 600w, https:\/\/www.unioviedo.es\/IUOPA\/wp-content\/uploads\/2022\/03\/OfertaTrabajo-800x255.jpg 800w, https:\/\/www.unioviedo.es\/IUOPA\/wp-content\/uploads\/2022\/03\/OfertaTrabajo-1200x382.jpg 1200w, https:\/\/www.unioviedo.es\/IUOPA\/wp-content\/uploads\/2022\/03\/OfertaTrabajo.jpg 1905w\" data-sizes=\"auto\" data-orig-sizes=\"(max-width: 1024px) 100vw, (max-width: 640px) 100vw, 1200px\" \/><\/a><\/span><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:40px;width:100%;\"><\/div><div class=\"fusion-text fusion-text-1\"><p>Abou-Alfa GK, Lau G, Kudo M, Chan SL, Kelley RK, Furuse J, Sukeepaisarnjaroen W, Kang YK, Dao TV, De Toni EN, Rimassa L, Breder V, Vasilyev A, Heurgu\u00e9 A, Tam VC, Mody K, Thungappa SC, Ostapenko Y, Yau T, Azevedo S, Varela M, Cheng AL, Qin S, Galle PR, Ali S, Gupta C, Makowsky M, Kurland JF, Negro A, Sangro B. Future Oncol. 2023 Sep 6. doi: 10.2217\/fon-2023-0486. Online ahead of print. PMID: 37671641<\/p>\n<p><b>Consulta la publicaci\u00f3n en el siguiente <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37671641\/\" target=\"_blank\" rel=\"noopener\">enlace<\/a><\/b><\/p>\n<div class=\"voc-detail__cmp voc-detail__cmp--pad-lr \">\n<div class=\"voc-ficha-detail__wrapper\">\n<section class=\"voc-ficha-detail\">\n<div class=\"voc-list__wrapper\"><\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:40px;width:100%;\"><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-column-0{width:100% !important;margin-top : 0px;margin-bottom : 0px;}.fusion-builder-column-0 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 1.92%;padding-bottom : 0px !important;padding-left : 0px !important;margin-left : 1.92%;}@media only screen and (max-width:1024px) {.fusion-body .fusion-builder-column-0{width:75% !important;order : 0;}.fusion-builder-column-0 > .fusion-column-wrapper {margin-right : 2.56%;margin-left : 2.56%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-column-0{width:100% !important;order : 0;}.fusion-builder-column-0 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-flex-container.fusion-builder-row-1{ padding-top : 0px;margin-top : 0px;padding-right : 30px;padding-bottom : 0px;margin-bottom : 0px;padding-left : 30px;}@media only screen and (max-width:1024px) {.fusion-body .fusion-flex-container.fusion-builder-row-1{ padding-top : 80px;}}<\/style><\/div><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-2 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"background-color: rgba(255,255,255,0);background-position: center center;background-repeat: no-repeat;border-width: 0px 0px 0px 0px;border-color:#eae9e9;border-style:solid;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start\" style=\"max-width:1216.8px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-1 fusion_builder_column_1_1 1_1 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 20px 0px 20px 0px;\"><div class=\"fusion-sharing-box fusion-sharing-box-1\" style=\"background-color:#f6f6f6;margin-top:60px;\" data-title=\"Plain language summary of the HIMALAYA study: tremelimumab and durvalumab for unresectable hepatocellular carcinoma (liver cancer).\" data-description=\"Abou-Alfa GK, Lau G, Kudo M, Chan SL, Kelley RK, Furuse J, Sukeepaisarnjaroen W, Kang YK, Dao TV, De Toni EN, Rimassa L, Breder V, Vasilyev A, Heurgu\u00e9 A, Tam VC, Mody K, Thungappa SC, Ostapenko Y, Yau T, Azevedo S, Varela M, Cheng AL, Qin S, Galle PR, Ali S, Gupta C,\" data-link=\"https:\/\/www.unioviedo.es\/IUOPA\/en\/plain-language-summary-of-the-himalaya-study-tremelimumab-and-durvalumab-for-unresectable-hepatocellular-carcinoma-liver-cancer\/\"><h4 class=\"tagline\" style=\"color:#2f2f2f;\">Compartir noticia<\/h4><div class=\"fusion-social-networks sharingbox-shortcode-icon-wrapper sharingbox-shortcode-icon-wrapper-1\"><span><a href=\"https:\/\/www.facebook.com\/sharer.php?u=https%3A%2F%2Fwww.unioviedo.es%2FIUOPA%2Fen%2Fplain-language-summary-of-the-himalaya-study-tremelimumab-and-durvalumab-for-unresectable-hepatocellular-carcinoma-liver-cancer%2F&amp;t=Plain%20language%20summary%20of%20the%20HIMALAYA%20study%3A%20tremelimumab%20and%20durvalumab%20for%20unresectable%20hepatocellular%20carcinoma%20%28liver%20cancer%29.\" target=\"_blank\" rel=\"noreferrer\" title=\"Facebook\" aria-label=\"Facebook\"><i class=\"fusion-social-network-icon fusion-tooltip fusion-facebook awb-icon-facebook\" style=\"color:#76b5ae;\" aria-hidden=\"true\"><\/i><\/a><\/span><span><a href=\"https:\/\/twitter.com\/share?text=Plain%20language%20summary%20of%20the%20HIMALAYA%20study%3A%20tremelimumab%20and%20durvalumab%20for%20unresectable%20hepatocellular%20carcinoma%20%28liver%20cancer%29.&amp;url=https%3A%2F%2Fwww.unioviedo.es%2FIUOPA%2Fen%2Fplain-language-summary-of-the-himalaya-study-tremelimumab-and-durvalumab-for-unresectable-hepatocellular-carcinoma-liver-cancer%2F\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"Twitter\" aria-label=\"Twitter\"><i class=\"fusion-social-network-icon fusion-tooltip fusion-twitter awb-icon-twitter\" style=\"color:#76b5ae;\" aria-hidden=\"true\"><\/i><\/a><\/span><span><a href=\"https:\/\/www.linkedin.com\/shareArticle?mini=true&amp;url=https%3A%2F%2Fwww.unioviedo.es%2FIUOPA%2Fen%2Fplain-language-summary-of-the-himalaya-study-tremelimumab-and-durvalumab-for-unresectable-hepatocellular-carcinoma-liver-cancer%2F&amp;title=Plain%20language%20summary%20of%20the%20HIMALAYA%20study%3A%20tremelimumab%20and%20durvalumab%20for%20unresectable%20hepatocellular%20carcinoma%20%28liver%20cancer%29.&amp;summary=Abou-Alfa%20GK%2C%20Lau%20G%2C%20Kudo%20M%2C%20Chan%20SL%2C%20Kelley%20RK%2C%20Furuse%20J%2C%20Sukeepaisarnjaroen%20W%2C%20Kang%20YK%2C%20Dao%20TV%2C%20De%20Toni%20EN%2C%20Rimassa%20L%2C%20Breder%20V%2C%20Vasilyev%20A%2C%20Heurgu%C3%A9%20A%2C%20Tam%20VC%2C%20Mody%20K%2C%20Thungappa%20SC%2C%20Ostapenko%20Y%2C%20Yau%20T%2C%20Azevedo%20S%2C%20Varela%20M%2C%20Cheng%20AL%2C%20Qin%20S%2C%20Galle%20PR%2C%20Ali%20S%2C%20Gupta%20C%2C\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"LinkedIn\" aria-label=\"LinkedIn\"><i class=\"fusion-social-network-icon fusion-tooltip fusion-linkedin awb-icon-linkedin\" style=\"color:#76b5ae;\" aria-hidden=\"true\"><\/i><\/a><\/span><span><a href=\"mailto:?subject=Plain%20language%20summary%20of%20the%20HIMALAYA%20study%3A%20tremelimumab%20and%20durvalumab%20for%20unresectable%20hepatocellular%20carcinoma%20%28liver%20cancer%29.&amp;body=https%3A%2F%2Fwww.unioviedo.es%2FIUOPA%2Fen%2Fplain-language-summary-of-the-himalaya-study-tremelimumab-and-durvalumab-for-unresectable-hepatocellular-carcinoma-liver-cancer%2F\" target=\"_self\" title=\"Correo electr\u00f3nico\" aria-label=\"Correo electr\u00f3nico\"><i class=\"fusion-social-network-icon fusion-tooltip fusion-mail awb-icon-mail\" style=\"color:#76b5ae;\" aria-hidden=\"true\"><\/i><\/a><\/span><\/div><\/div><style type=\"text\/css\">.fusion-sharing-box-1 h4{margin-bottom:0 !important;}.fusion-sharing-box-1{flex-direction:row !important;padding-top:20px !important;padding-bottom:20px !important;}.sharingbox-shortcode-icon-wrapper-1 span.sharingbox-shortcode-icon-separator{border-right-width:0px !important;}@media only screen and (max-width:1024px){.fusion-sharing-box-1 h4{margin-right:0.5em !important;margin-bottom:0 !important;}.sharingbox-shortcode-icon-wrapper-1{width:auto !important;justify-content:flex-end !important;}.fusion-sharing-box-1{align-items:center !important;} }@media only screen and (max-width:640px){.fusion-sharing-box-1{flex-direction: column !important;align-items:center !important;}.fusion-sharing-box-1 h4{margin-bottom:revert !important;}.sharingbox-shortcode-icon-wrapper-1{width:100% !important;justify-content:space-between !important;} }<\/style><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-column-1{width:100% !important;margin-top : 0px;margin-bottom : 0px;}.fusion-builder-column-1 > .fusion-column-wrapper {padding-top : 20px !important;padding-right : 0px !important;margin-right : 1.92%;padding-bottom : 20px !important;padding-left : 0px !important;margin-left : 1.92%;}@media only screen and (max-width:1024px) {.fusion-body .fusion-builder-column-1{width:100% !important;order : 0;}.fusion-builder-column-1 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-column-1{width:100% !important;order : 0;}.fusion-builder-column-1 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-flex-container.fusion-builder-row-2{ padding-top : 0px;margin-top : 0px;padding-right : 30px;padding-bottom : 0px;margin-bottom : 0px;padding-left : 30px;}<\/style><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":1824,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[82],"tags":[162],"class_list":["post-3090","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-publications","tag-actualidad-iuopa-en"],"_links":{"self":[{"href":"https:\/\/www.unioviedo.es\/IUOPA\/wp-json\/wp\/v2\/posts\/3090","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.unioviedo.es\/IUOPA\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.unioviedo.es\/IUOPA\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.unioviedo.es\/IUOPA\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.unioviedo.es\/IUOPA\/wp-json\/wp\/v2\/comments?post=3090"}],"version-history":[{"count":1,"href":"https:\/\/www.unioviedo.es\/IUOPA\/wp-json\/wp\/v2\/posts\/3090\/revisions"}],"predecessor-version":[{"id":3091,"href":"https:\/\/www.unioviedo.es\/IUOPA\/wp-json\/wp\/v2\/posts\/3090\/revisions\/3091"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.unioviedo.es\/IUOPA\/wp-json\/wp\/v2\/media\/1824"}],"wp:attachment":[{"href":"https:\/\/www.unioviedo.es\/IUOPA\/wp-json\/wp\/v2\/media?parent=3090"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.unioviedo.es\/IUOPA\/wp-json\/wp\/v2\/categories?post=3090"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.unioviedo.es\/IUOPA\/wp-json\/wp\/v2\/tags?post=3090"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}